Reimbursement Criteria for Palivizumab (Synagis®)

---

2011-2012 RSV Season

Criteria for Reimbursement of Palivizumab (Synagis®) for the 2011-2012 RSV Season - Pharmacists 9/2/11

Criteria for Reimbursement of Palivizumab (Synagis®) for the 2011-2012 RSV Season – Prescribing Practitioners 10/6/11

Criteria for Reimbursement of Palivizumab (Synagis®) for the 2011-2012 RSV Season – Home Health Providers 10/6/11

2010-2011 RSV Season

Criteria for Reimbursement of Palivizumab (Synagis®) for the 2010-2011 RSV Season - Pharmacists 9/16/10

Criteria for Reimbursement of Palivizumab (Synagis®) for the 2010-2011 RSV Season – Prescribing Providers 9/16/10

 

2009-2010 RSV Season

Prescribing Practitioner Update to Reimbursement Criteria for Palivizumab (Synagis) Letter 3/18/10

Pharmacist Update to Reimbursement Criteria for Palivimab (Synagis) Letter 3/18/10

Criteria for Reimbursement of Synagis®, Antipsychotic Agents, and Agents Used to Treat ADD - Prescribing Providers Effective October 1, 2009

Criteria for Reimbursement of Synagis®, Antipsychotic Agents, and Agents Used to Treat ADD - Pharmacists  Effective October 1, 2009